Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
JOHN HANCOCK DIVERSIFIED INCOME FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)
-
Wellington Management Deepens Commitment to Wealth Channel With Senior Leadership Hire
-
Dataiku Announces 2025 Partner Award Winners
-
Form 13F-HR/A WELLINGTON MANAGEMENT For: Dec 31
-
Foregoing Banking-as-a-Service: Case study concludes Current's core banking technology provides a key edge in the market
-
Dataiku and Deloitte Deliver Analytics Modernization Program
-
Bond investors brace for US slowdown, shed risk as Fed seen on hold
-
Vanguard Announces Advisory Changes for Vanguard International Explorer Fund
-
FalconX Executes First-Ever CME Group SOL Futures Trade with StoneX
-
74% of CEOs Admit They Could Lose Their Job Within 2 Years if They Don’t Deliver Measurable AI Business Gains, Reveals Dataiku’s “Global AI Confessions Report: CEO Edition”
-
Form D/A Wellington Management
-
Form SCHEDULE 13G/A Shoals Technologies Grou Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Syndax Pharmaceuticals Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A EchoStar CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A agilon health, inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
TS Conductor Announces New South Carolina Manufacturing Facility to Meet Growing Grid Modernization Needs
-
Wellington Management Expands Private Investing Capabilities With Formation of a Private Real Estate Credit Platform
-
Genius Sports Reports Fourth Quarter and Full-Year 2024 Results and Announces 2025 Outlook for 21% Group Revenue Growth and 20% Group Adj. EBITDA Margin
-
BridgeBio Oncology Therapeutics to go Public via Merger with Helix Acquisition Cp II (HLXB)
-
BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Tar
-
Ondo Finance Joins the Mastercard Multi-Token Network (MTN) as the First Real-World Asset (RWA) Provider
-
Just Salad Raises $200M to Accelerate Growth, Make Everyday Health and Sustainability Possible
-
Just Salad raises new funding at $1 billion valuation
-
Fed's QT pause, Treasury's debt plans may offer fleeting relief to US bonds
-
Wellington Management Raises $194 Million for its First CLO Partners Fund
-
Jito Foundation and FalconX to Bring Staking Returns and MEV Rewards to Institutional Traders
-
Land & Buildings Nominates Two Independent Candidates – Jim Hoffmann and Adam Troso – for Board of National Health Investors
-
Medincell Announces Successful c.€43 Million Global Offering
-
Sohn Montreal Investment Conference Announces Speaker Lineup for Inaugural May 2025 Event
-
Form 13F-HR WELLINGTON MANAGEMENT For: Dec 31
-
Form 13F-NT Wellington Management For: Dec 31
-
Form 13F-NT Wellington Management For: Dec 31
-
Form 13F-NT WELLINGTON MANAGEMENT For: Dec 31
-
Form 13F-NT Wellington Management For: Dec 31
-
Form 13F-NT Wellington Management For: Dec 31
-
Form 13F-NT Wellington Management For: Dec 31
-
Form 13F-NT Wellington Management For: Dec 31
-
Archer Aviation raises $300 million in BlackRock-backed funding
-
PHȲND Raises $10M Oversubscribed Seed Round for Revolutionary Free Smart TV Gaming Platform
-
Form SCHEDULE 13G/A M&T BANK CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Apellis Pharmaceuticals, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A GENERAL DYNAMICS CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G IDEX CORP /DE/ Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Guardian Pharmacy Servic Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Kymera Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A MVB FINANCIAL CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Encompass Health Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A FMC CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Disc Medicine, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A ROCKET PHARMACEUTICALS, Filed by: WELLINGTON MANAGEMENT GROUP LLP

